View Agent
| Agent Info | |
| Agent: | figitumumab |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | Malignant adrenal gland cancer(Discontinued inphase 1) |
| Classification: | a fully human IgG2 monoclonal antibody targeting the insulin-like growth-factor-1 receptor (IGF-1R) |
| Target: | Insulin-like growth factor I receptor |
| KEGG Pathway: | Pathways in cancer Rap1 signaling pathway Ovarian steroidogenesis Signaling pathways regulating pluripotency of stem cells Focal adhesion Endocytosis FoxO signaling pathway HIF-1 signaling pathway Proteoglycans in cancer Oocyte meiosis Progesterone-mediated oocyte maturation PI3K-Akt signaling pathway Melanoma Prostate cancer Adherens junction AMPK signaling pathway Ras signaling pathway Glioma |
| Wiki Pathway: | Signaling Pathways in Glioblastoma Senescence and Autophagy in Cancer Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) Apoptosis Endochondral Ossification Focal Adhesion MicroRNAs in cardiomyocyte hypertrophy Insulin Signaling TSH signaling pathway |